- Home
- ACLX vs PRVA Comparison
ACLX vs PRVA Comparison
Compare ACLX & PRVA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ACLX
- PRVA
- Stock Information
- Founded
- ACLX 2015
- PRVA 2007
- Country
- ACLX United States
- PRVA United States
- Employees
- ACLX N/A
- PRVA N/A
- Industry
- ACLX Biotechnology: Pharmaceutical Preparations
- PRVA Retail: Computer Software & Peripheral Equipment
- Sector
- ACLX Health Care
- PRVA Technology
- Exchange
- ACLX Nasdaq
- PRVA Nasdaq
- Market Cap
- ACLX 3.3B
- PRVA 2.8B
- IPO Year
- ACLX 2022
- PRVA 2021
- Fundamental
- Price
- ACLX $61.93
- PRVA $22.83
- Analyst Decision
- ACLX Strong Buy
- PRVA Strong Buy
- Analyst Count
- ACLX 13
- PRVA 14
- Target Price
- ACLX $111.55
- PRVA $27.93
- AVG Volume (30 Days)
- ACLX 1.1M
- PRVA 770.2K
- Earning Date
- ACLX 05-08-2025
- PRVA 05-08-2025
- Dividend Yield
- ACLX N/A
- PRVA N/A
- EPS Growth
- ACLX N/A
- PRVA N/A
- EPS
- ACLX N/A
- PRVA 0.12
- Revenue
- ACLX $76,809,000.00
- PRVA $1,801,244,000.00
- Revenue This Year
- ACLX N/A
- PRVA $90.57
- Revenue Next Year
- ACLX $119.90
- PRVA $10.43
- P/E Ratio
- ACLX N/A
- PRVA $189.74
- Revenue Growth
- ACLX N/A
- PRVA 6.79
- 52 Week Low
- ACLX $47.86
- PRVA $16.37
- 52 Week High
- ACLX $107.37
- PRVA $26.09
- Technical
- Relative Strength Index (RSI)
- ACLX 50.64
- PRVA 42.61
- Support Level
- ACLX $60.67
- PRVA $22.72
- Resistance Level
- ACLX $64.78
- PRVA $23.73
- Average True Range (ATR)
- ACLX 4.19
- PRVA 0.73
- MACD
- ACLX 0.35
- PRVA -0.21
- Stochastic Oscillator
- ACLX 52.83
- PRVA 21.00
About ACLX Arcellx Inc.
Arcellx Inc is a clinical-stage biotechnology company reimagining cell therapy through the development of immunotherapies for patients with cancer and other incurable diseases.
About PRVA Privia Health Group Inc.
Privia Health Group Inc is a technology-driven, national physician-enablement company. It collaborates with medical groups, health plans, and health systems to optimize physician practices, improve patient experiences, and reward doctors for delivering high-value care in both in-person and virtual care settings.